ANXA6 and osteoarthritis: Furthermore, in articular chondrocytes from control animals, AnxA6 associates with the plasma membrane to interfere with Wnt/b-catenin signaling, affecting crosstalk with NFκB signaling, catabolic and inflammatory events, all of which contributing to cartilage degradation in osteoarthritis [318].